Completed NA INTERVENTIONAL 2-arm NCT00175227

Prevention of Contrast-Induced Nephropathy

Prevention of Contrast-Induced Nephropathy: a Randomized Controlled Trial of Saline + Furosemide + Mannitol in High Risk Patients Undergoing Cardiac Angiography

Sponsor: Alberta Heritage Foundation for Medical Research

Conditions Acute Renal Failure Chronic Renal Failure Contrast-induced Nephropathy

Interventions intravenous saline hydration intravenous saline hydration + mannitol + furosemide

Updated 5 times since 2017 Last updated: May 9, 2011 Started: May 31, 1996 Primary completion: Oct 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Renal Failure and Chronic Renal Failure and is currently completed. Alberta Heritage Foundation for Medical Research leads this study, which shows 5 recorded versions since 1996 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alberta Heritage Foundation for Medical Research
University of Alberta

Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada